Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5932-27-4

Post Buying Request

5932-27-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5932-27-4 Usage

General Description

Ethyl pyrazole-3-carboxylate is a chemical compound with the molecular formula C7H8N2O2. It is an ester derivative of pyrazole carboxylic acid and is commonly used in organic synthesis and medicinal chemistry. Ethyl pyrazole-3-carboxylate possesses insecticidal and fungicidal properties, making it a potential candidate for the development of agrochemicals. It is also utilized as an intermediate in the production of pharmaceuticals and other organic compounds. Furthermore, it has been studied for its potential anti-cancer and anti-inflammatory activities, highlighting its diverse range of applications in various fields. Overall, ethyl pyrazole-3-carboxylate is a versatile and important chemical compound with multiple uses and potential therapeutic properties.

Check Digit Verification of cas no

The CAS Registry Mumber 5932-27-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,9,3 and 2 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 5932-27:
(6*5)+(5*9)+(4*3)+(3*2)+(2*2)+(1*7)=104
104 % 10 = 4
So 5932-27-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2O2/c1-2-10-6(9)5-3-4-7-8-5/h3-4H,2H2,1H3,(H,7,8)

5932-27-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (725293)  Ethyl3-pyrazolecarboxylate  97%

  • 5932-27-4

  • 725293-1G

  • 1,164.15CNY

  • Detail

5932-27-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 3-Pyrazolecarboxylate

1.2 Other means of identification

Product number -
Other names Ethyl pyrazole-3-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5932-27-4 SDS

5932-27-4Relevant articles and documents

Vinyldiazo Compounds as 3-Carbon Radical Acceptors: Synthesis of 4-Fluoroacridines via Visible-Light-Promoted Cascade Radical Cyclization

Li, Weiyu,Zhou, Lei

, p. 4279 - 4283 (2021)

Vinyldiazo reagents were developed as the radical acceptors in a visible-light-promoted sequential radical cyclization reaction, providing a mechanistically distinct pathway to achieve (3 + 3) cyclization. Using N-aryl chlorodifluoromethyl alkynyl ketoimines as the radical precursors, the reaction allows the introduction of a fluorine atom to the acridine skeleton during the construction of both the pyridine and benzene motifs from acyclic building blocks. The resulting 4-fluoroacridines exhibited pronounced fluorescent properties in the solid state.

1-vinyl-3- and 1-vinyl-5-pyrazolecarboxylic acids. synthesis and anti-burn activity of their chitosan salts

Rstakyan,Akopyan,Saakyan,Attaryan,Asratyan

, p. 1945 - 1949 (2014)

The synthesis of 1-vinyl-3- and 1-vinyl-5-pyrazolcarboxylic acids is developed and the anti burn activity of the chitosan salts of 1-vinyl-3(5)-carboxylic acids is studied.

Design, synthesis and biological evaluation of ring-fused pyrazoloamino pyridine/pyrimidine derivatives as potential FAK inhibitors

Xie, Hongming,Lin, Xinglong,Zhang, Yingjun,Tan, Fuxing,Chi, Bo,Peng, Zhihong,Dong, Wanrong,An, Delie

supporting information, (2020/10/06)

We report herein the synthesis of novel ring-fused pyrazoloamino pyridine/pyrimidine derivatives as potential FAK inhibitors and the evaluation of pharmaceutical activity against five cancer cell lines (MDA-MB-231, BXPC-3, NCI-H1975, DU145 and 786O). Generally, the majority of compounds displayed strong anti-FAK enzymatic potencies (IC50 1 nM) and could effectively inhibit several class of cancer cell lines within the concentration of 3 μM in comparison with GSK2256098 as a reference. Among them, compound 4o is considered to be the most effective due to high sensitivity in antiproliferation. In culture, 4o could not only inhibit FAK Y397 phosphorylation in MDA-MB-231 cell line, but also trigger apoptosis in a dose-dependent manner. Furthermore, computational docking analysis also suggested that 4o and TAE-226 displayed the similar interaction with FAK kinase domain.

Structure Kinetics Relationships and Molecular Dynamics Show Crucial Role for Heterocycle Leaving Group in Irreversible Diacylglycerol Lipase Inhibitors

Janssen, Antonius P.A.,Van Hengst, Jacob M.A.,Béquignon, Olivier J.M.,Deng, Hui,Van Westen, Gerard J.P.,Van Der Stelt, Mario

, p. 7910 - 7922 (2019/10/11)

Drug discovery programs of covalent irreversible, mechanism-based enzyme inhibitors often focus on optimization of potency as determined by IC50-values in biochemical assays. These assays do not allow the characterization of the binding activity (Ki) and reactivity (kinact) as individual kinetic parameters of the covalent inhibitors. Here, we report the development of a kinetic substrate assay to study the influence of the acidity (pKa) of heterocyclic leaving group of triazole urea derivatives as diacylglycerol lipase (DAGL)-α inhibitors. Surprisingly, we found that the reactivity of the inhibitors did not correlate with the pKa of the leaving group, whereas the position of the nitrogen atoms in the heterocyclic core determined to a large extent the binding activity of the inhibitor. This finding was confirmed and clarified by molecular dynamics simulations on the covalently bound Michaelis-Menten complex. A deeper understanding of the binding properties of covalent serine hydrolase inhibitors is expected to aid in the discovery and development of more selective covalent inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5932-27-4